diseas
progress
aid
infect
individu
becom
increasingli
immunosuppress
suscept
opportunist
infect
also
demonstr
multipl
subset
dendrit
cell
dc
includ
dcsign
cell
becom
significantli
deplet
blood
lymphoid
tissu
aid
patient
may
contribut
failur
initi
effect
host
immun
respons
mechan
dc
deplet
howev
unclear
also
known
vast
quantiti
viral
envelop
protein
shed
matur
virion
form
circul
immun
complex
serum
individu
patholog
role
pathogenesi
remain
elus
describ
previous
unrecogn
mechan
dc
death
chronic
infect
ligat
dcsign
sensit
dc
undergo
acceler
apoptosi
respons
varieti
activ
stimuli
cultur
monocytederiv
dc
also
freshlyisol
dcsign
blood
dc
expos
either
crosslink
recombin
immunecomplex
hiv
serum
underw
consider
apoptosi
ligat
exposur
bacteri
lipopolysaccharid
lp
proinflammatori
cytokin
tnfa
furthermor
circul
dcsign
dc
isol
directli
individu
actual
presensit
serum
activationinduc
exorbit
apoptosi
case
dc
apoptosi
substanti
inhibit
dcsign
blockad
final
show
acceler
dc
apoptosi
direct
consequ
excess
activ
proapoptot
molecul
transfect
sirna
significantli
prevent
activationinduc
excess
dc
death
studi
disclos
previous
unknown
mechan
immun
modul
envelop
protein
provid
new
insight
hiv
immunopathogenesi
suggest
potenti
therapeut
approach
prevent
dc
deplet
chronic
hiv
infect
envelop
protein
bind
chemokin
receptor
express
dendrit
cell
dc
facilit
viral
entri
cell
also
readili
shed
matur
virion
form
immun
complex
plasma
hivinfect
hiv
individu
consequ
tini
portion
circul
virion
actual
infecti
addit
bind
dcspecif
icamgrab
nonintegrin
dcsign
initi
intracellular
signal
cascad
promot
viral
infect
dissemin
cell
subset
dcsign
dc
identifi
blood
bind
transmit
infecti
viru
cell
viru
activ
replic
activ
cell
chronic
induc
hiv
infect
variou
mechan
progress
aid
hiv
individu
becom
increasingli
immunosuppress
suscept
opportunist
infect
cancer
accompani
progress
deplet
dc
differ
anatom
compart
reason
remain
larg
unknown
exampl
demonstr
situ
hybrid
dcsign
express
significantli
reduc
spleen
sivinduc
aid
furthermor
latestag
hiv
infect
dramat
deplet
lymph
node
myeloid
dc
mdc
also
observ
mdc
less
frequent
hiv
node
control
node
consist
anoth
report
employ
flow
cytometri
immunofluoresc
studi
show
frequenc
lymph
node
mdc
significantli
decreas
model
simian
aid
suggest
mdc
lost
rather
recruit
lymphoid
tissu
advanc
siv
infect
addit
mdc
sivinfect
anim
undergo
spontan
cell
death
cultur
support
hypothesi
loss
mdc
may
due
cell
death
moreov
dc
annexin
vposit
could
identifi
lymph
node
monkey
aid
indic
dc
ln
may
undergo
apoptosi
normal
circumst
lifespan
avail
dc
vivo
crucial
induct
mainten
effect
antigenspecif
cell
immun
exampl
magnitud
qualiti
cell
respons
proport
number
antigenbear
dc
reach
lymph
node
normal
migrat
dc
peripher
nonlymphoid
site
secondari
lymphoid
tissu
promot
dc
matur
process
cell
acquir
enhanc
capac
cell
activ
regul
immun
respons
peripher
site
infect
inflamm
dc
matur
induc
stimuli
bacteri
lipopolysaccharid
lp
proinflammatori
cytokin
tnfa
ilb
within
lymphoid
tissu
dc
activ
induc
activ
cell
upregul
ligand
ligat
dc
dc
undergo
apoptosi
tightlyregul
process
accumul
evid
demonstr
balanc
surviv
versu
apoptosi
dc
control
differenti
express
antiand
proapoptot
molecul
induc
differ
cellular
respons
exampl
matur
stimuli
activ
phosphatydylinositid
phosphoryl
akt
pakt
turn
increas
express
antiapoptot
protein
bclxl
shown
bind
dcsign
recruit
effector
protein
dcsign
signalosom
phosphoryl
activ
praf
antiapoptot
turn
antagon
function
anoth
mapkkk
apoptosi
signal
regul
also
activ
stimuli
proapoptot
least
part
capac
reduc
express
bclxl
regul
dc
surviv
peripher
lymphoid
tissu
crucial
initi
regul
immun
respons
reduct
dc
number
would
result
generalis
immunosuppress
increas
suscept
opportunist
infect
observ
diseas
progress
aid
previous
report
chemotaxi
monocytederiv
dc
modc
induc
mtropic
strain
bind
find
may
part
explain
observ
acut
infect
rapid
accumul
dcsign
cell
within
lymphoid
tissu
contrast
diseas
progress
chronic
aid
circul
lymphoid
tissueassoci
dc
becom
progress
deplet
includ
dcsign
dc
markedli
reduc
lymph
node
aid
patient
spleen
nonhuman
primat
sivinduc
aid
clinic
observ
indic
increas
serum
viral
load
correl
well
decreas
number
dc
individu
suggest
viru
viral
product
shed
may
directli
impact
dc
surviv
much
work
focuss
mechan
immun
subvers
infecti
virion
rel
scant
attent
paid
potenti
immunomodulatori
effect
vast
amount
immun
complex
within
circul
hiv
individu
hypothesis
bind
dcsign
dc
may
impact
surviv
thu
contribut
cellular
deplet
observ
set
show
dc
expos
either
vitro
vivo
undergo
acceler
apoptosi
expos
multipl
stimuli
normal
induc
dc
matur
crucial
also
demonstr
bind
dcsign
result
excess
activ
silenc
effect
revers
process
promot
dc
surviv
first
studi
surviv
dc
expos
activ
cell
mimick
interact
typic
occur
within
secondari
lymphoid
tissu
monocytederiv
dc
modc
treat
antibodi
crosslink
recombin
cocultur
activ
cell
readili
identifi
within
cocultur
distinct
larg
granular
dcsign
cell
popul
fig
analysi
annexinv
av
propidium
iodid
pi
express
popul
reveal
high
proport
underw
apoptosi
follow
cocultur
activ
cell
fig
right
upper
vs
lower
panel
treatment
modc
crosslink
clearli
induc
apoptosi
dosedepend
fig
timedepend
fig
author
summari
infect
individu
becom
increasingli
immunocompromis
suscept
opportunist
infect
diseas
progress
associ
signific
reduct
dendrit
cell
number
peripher
blood
secondari
lymphoid
tissu
dendrit
cell
power
antigenpres
cell
surviv
critic
host
defenc
inadequ
dendrit
cell
number
fail
induc
effect
host
immun
respons
describ
mechan
may
least
partli
explain
dendrit
cell
becom
significantli
deplet
chronic
infect
found
bind
envelop
protein
dendrit
cell
surfac
protein
dcsign
subsequ
activ
ligat
exposur
bacteri
product
lipopolysaccharid
proinflammatori
cytokin
tnfa
lead
overexpress
proapoptot
molecul
result
excess
dendrit
cell
death
also
confirm
dcsign
dendrit
cell
blood
infect
individu
actual
presensit
viral
exist
vast
amount
blood
activationinduc
exorbit
death
studi
thu
reveal
previous
unknown
pathway
dendrit
cell
deplet
provid
clue
potenti
therapeut
approach
prevent
dc
deplet
chronic
hiv
infect
figur
crosslink
recombin
sensit
modc
apoptosi
cocultur
activ
cell
modc
treat
h
antihi
mab
alon
control
dc
left
panel
nm
ada
crosslink
antihi
mab
right
panel
cocultur
autolog
activ
upper
panel
lower
panel
cell
modc
fig
analyz
annexin
v
av
propidium
iodid
pi
express
assess
extent
apoptosi
manifest
percentag
avposit
av
cell
data
repres
experi
b
apoptosi
modc
analyz
treatment
differ
concentr
crosslink
recombin
ada
cocultur
activ
cell
dc
treat
monomer
crosslink
antihi
antiflag
mab
use
control
data
repres
mean
sd
experi
use
crosslink
recombin
bal
gave
similar
result
shown
c
apoptosi
modc
analyz
treatment
indic
crosslink
recombin
appropri
mab
control
indic
time
point
cocultur
activ
cell
data
repres
mean
sd
experi
data
antihi
antiflag
control
indistinguish
compar
control
group
dc
puls
dc
plu
antihisflag
ab
modc
respect
treat
control
dc
treat
ada
crosslink
mous
antihi
mab
dimer
treat
crosslink
ada
supplement
isotyp
control
mous
igg
igg
subsequ
cocultur
autolog
activ
cell
day
avpi
stain
data
repres
experi
e
modc
treat
crosslink
ada
cocultur
autolog
activ
cell
pretreat
without
mgml
isotyp
control
mab
cell
viabil
analysi
data
express
mean
sd
experi
manner
preliminari
timechas
experi
follow
avpi
reactiv
till
found
av
reactiv
dc
reduc
wherea
pi
increas
time
indic
incub
time
increas
cell
earli
apoptot
phase
would
becom
late
apoptot
avpi
cell
nevertheless
overal
av
cell
ie
plu
avpi
cell
remain
rel
consist
figur
therefor
chose
observ
time
point
compar
total
av
cell
among
variou
treatment
condit
furthermor
crosslink
prompt
dc
activ
cellmedi
apoptosi
treatment
monomer
fig
format
dimer
crosslink
anti
tag
antihi
antiflag
ab
confirm
nativ
nonreduc
western
blot
analysi
fig
crosstalk
dc
activ
cell
interact
play
crucial
role
regul
dc
surviv
immun
respons
examin
potenti
involv
interact
induct
apoptosi
activ
cell
pretreat
antagonist
mab
cocultur
pretreat
significantli
inhibit
apoptosi
fig
therefor
activ
cellmedi
apoptosi
immunecomplex
dc
least
part
dcsign
one
major
surfac
molecul
bind
modc
examin
role
dcsign
cellinduc
dc
apoptosi
pretreat
dc
antidcsign
mab
mixtur
clone
combin
antidcsign
mab
use
studi
substanti
reduc
bind
dcsign
inhibit
uptak
fig
dcsigntransfect
inde
dcsign
blockad
could
significantli
prevent
dc
apoptosi
upon
cocultur
activ
cell
fig
b
apoptosi
dc
studi
exposur
l
tf
would
lead
outcom
analys
avpi
express
modc
express
hladr
fig
separ
adher
transfect
express
high
level
littl
hladr
fig
found
exposur
tf
cell
also
induc
signific
apoptosi
compar
exposur
mock
l
cell
transfect
fig
top
panel
fig
cell
death
confirm
trypan
blue
stain
fig
next
tri
delin
role
receptor
apart
dcsign
modc
might
also
respons
apoptosi
first
pretreat
modc
receptor
antidcsign
mab
previous
describ
puls
dc
crosslink
recombin
cocultur
tf
cell
day
result
show
contrast
dcsign
blockad
pretreat
combin
receptor
mab
inhibit
modc
apoptosi
fig
pretreat
modc
crosslink
physiolog
ligand
dcsign
fig
prevent
bind
also
ineffect
prevent
apoptosi
fig
control
studi
demonstr
pretreat
antagonist
mab
alon
sensit
modc
cell
death
fig
taken
togeth
conclud
crosslink
dcsign
receptor
recombin
sensit
dc
apoptosi
ligat
bind
modc
shown
exclus
carbohydratedepend
also
examin
role
carbohydr
mannos
ctype
lectin
receptor
mclr
addit
dcsign
could
also
involv
death
adopt
two
approach
remov
carbohydr
moieti
recombin
endoh
endobnglucosaminidas
crosslink
anti
tag
ab
pretreat
dc
mannan
compet
bind
dc
express
abund
fcr
fcr
crosslink
may
induc
apoptosi
certain
cell
also
investig
effect
fcr
blockad
prior
puls
endoh
treatment
deglycosyl
monomer
reduc
molecular
weight
kda
reduc
kda
crosslink
dimer
form
inde
lost
bind
capac
modc
fig
furthermor
immunecomplex
endohtr
lost
abil
sensit
dc
apoptosi
upon
ligat
fig
upper
row
fig
pretreat
modc
mannan
prior
puls
also
complet
prevent
apoptosi
potent
mere
dcsign
blockad
moreov
fcr
blockad
induc
apoptosi
control
dc
puls
anti
tag
ab
significantli
promot
extent
apoptosi
immun
complex
sera
hivposit
individu
sensitis
cultur
dendrit
cell
apoptosi
investig
whether
sera
individu
contain
suffici
level
immun
complex
sensit
modc
apoptosi
next
treat
modc
sera
contain
high
viral
copi
number
tabl
order
elimin
effect
solubl
immun
factor
sera
first
centrifug
filter
cutoff
point
kda
kda
fraction
collect
reconstitut
origin
volum
fresh
medium
use
describ
cocultur
autolog
activ
cell
seratr
modc
identifi
smallers
popul
control
modc
fig
cell
subject
tunel
assay
flow
cytometr
analysi
evalu
termin
deoxynucleotidyl
transferas
tdt
express
measur
apoptosi
confirm
hiv
serumpuls
modc
undergon
remark
apoptosi
fig
could
substanti
inhibit
pretreat
antidcsign
mab
fig
b
mab
fig
furthermor
excess
apoptosi
modc
effect
prevent
remov
sera
immunoprecipit
ip
fig
condit
also
deplet
virion
cultur
live
viru
fig
similar
result
obtain
follow
cocultur
serumtr
modc
tf
cell
confirm
chemokin
receptor
involv
sensit
apoptosi
fig
therefor
sera
may
contain
suffici
level
immun
complex
andor
virionbound
sensit
modc
apoptosi
next
investig
rel
contribut
circul
virion
hiv
serum
sensit
dc
apoptosi
first
treat
modc
kda
fraction
sera
contain
either
rel
low
high
viral
copi
number
tabl
cocultur
tf
cell
extent
dc
apoptosi
significantli
higher
treatment
serum
rel
high
hiv
rna
viral
load
fig
next
fraction
kda
serum
fraction
virionfre
kda
virionenrich
kda
portion
modc
treat
respect
fraction
cocultur
tf
cell
detect
slightli
higher
level
apoptosi
treatment
virionenrich
portion
control
substanti
level
apoptosi
observ
treatment
virionfre
portion
fig
henc
circul
immun
complex
hiv
sera
play
signific
role
virusbound
sensit
dc
apoptosi
separ
experi
also
examin
sensit
capac
endohtr
pretreat
mannan
c
modc
treat
crosslink
recombin
ada
without
pretreat
solubl
chimer
protein
plu
mab
antidcsign
mab
cell
subsequ
cocultur
mockor
tf
cell
data
repres
experi
panel
c
express
mean
sd
n
e
f
recombin
ada
treat
without
endoh
crosslink
antihi
ab
use
puls
modc
prior
puls
modc
pretreat
without
mannan
fcr
block
reagent
antidcsign
mab
minut
puls
dc
subsequ
cocultur
tf
day
dc
without
pretreat
puls
antihi
ab
use
control
control
dc
data
repres
experi
express
mean
sd
experi
f
well
fcr
blockad
dc
apoptosi
consist
case
recombin
fig
f
endohtr
hiv
serum
lost
capac
prime
dc
apoptosi
furthermor
compar
dcsign
blockad
pretreat
dc
mannan
puls
hiv
serum
prevent
dc
apoptosi
background
level
fcr
blockad
dc
prior
exposur
hiv
serum
increas
extent
dc
death
fig
blood
dc
healthi
individu
sensit
apoptosi
presensit
within
circul
individu
extend
studi
beyond
use
vitrogener
dc
next
purifi
dcsign
subset
dc
peripher
blood
normal
individu
approxim
cell
blood
express
dcsign
fig
equival
pbmc
also
express
fig
consist
previou
report
prime
crosslink
cocultur
tf
cell
bloodderiv
dc
also
underw
excess
apoptosi
significantli
reduc
prior
blockad
dcsign
fig
henc
bona
fide
primari
human
blood
dc
subset
sensit
ligat
dcsign
apoptosi
base
find
hypothes
dcsign
dc
peripher
blood
individu
would
excess
vulner
apoptosi
due
continu
exposur
high
level
immunecomplex
circul
therefor
also
isol
dcsign
dc
subset
directli
blood
individu
found
substanti
degre
apoptosi
occur
cultur
tf
cell
wherea
subset
dc
modc
treat
hiv
serum
immunoprecipit
ip
mab
without
antidcsign
isotyp
control
mab
subsequ
cocultur
autolog
activ
cell
cell
harvest
subject
tunel
assay
cell
death
assess
percentag
cell
express
termin
deoxynucleotidyl
transferas
tdt
dc
puls
hiv
serum
without
cocultur
activ
cell
top
panel
also
use
control
data
repres
experi
b
modc
treat
antidcsign
mab
isotyp
control
ab
mab
puls
hiv
serum
immunoprecipit
cocultur
activ
cell
data
express
mean
sd
n
compar
hiv
serumdc
plu
isotyp
ab
c
modc
treat
normal
ab
serum
serum
viral
rna
copi
tabl
without
pretreat
plu
chemokin
receptor
antidcsign
mab
immunoprecipit
ip
hiv
serum
cocultur
tf
data
repres
experi
panel
c
individu
datum
mean
shown
panel
without
ip
hiv
serum
without
pretreat
antidcsign
mab
hiv
individu
fig
thu
conclud
dcsign
dc
healthi
human
blood
sensit
apoptosi
vitro
exposur
crosslink
dcsign
circul
hiv
individu
may
presensitis
vivo
circul
immun
complex
sensit
cultur
dc
blood
dc
apoptosi
exposur
lp
tnfa
next
studi
surviv
dc
exposur
typic
stimuli
might
encount
peripher
site
infect
inflamm
prior
dc
migrat
lymphoid
tissu
modc
treat
crosslink
recombin
subsequ
cultur
ngml
lp
tnfa
consider
level
apoptosi
induc
dc
exposur
lp
could
significantli
prevent
prior
blockad
dcsign
fig
likewis
substanti
level
apoptosi
also
induc
exposur
tnfa
fig
excess
apoptosi
induc
crosslink
replac
sera
contain
high
viral
load
rna
copiesml
prior
lp
stimul
prevent
prior
immunoprecipit
sera
substanti
reduc
blockad
dcsign
fig
extrapol
find
vivo
set
dcsign
cell
peripher
blood
individu
isol
expos
ngml
lp
tnfa
littl
apoptosi
blood
dc
hiv
individu
blood
dcsign
dc
hiv
individu
underw
substanti
apoptosi
indic
presensit
vivo
die
contact
multipl
stimuli
otherwis
induc
dc
matur
fig
bind
dcsign
promot
apoptosi
human
dendrit
cell
explor
potenti
mechan
ligat
dcsign
sensit
dc
apoptosi
first
note
treatment
modc
crosslink
alon
abl
modul
express
key
membran
molecul
manner
typic
associ
dc
matur
fig
report
other
togeth
earlier
observ
fig
cf
apoptosi
vs
control
dc
find
suggest
ligat
dcsign
greatli
acceler
apoptot
programm
normal
induc
follow
matur
studi
compon
intracellular
signal
pathway
might
involv
sensit
dc
apoptosi
modc
treat
crosslink
hiv
sera
cocultur
tf
cell
expos
lp
tnfa
day
modc
harvest
cultur
western
blot
assay
perform
analyz
express
key
molecul
regul
balanc
dc
surviv
versu
death
first
note
substanti
reduct
express
level
antiapoptot
molecul
fig
bclxl
fig
exposur
crosslink
fig
hiv
seratr
modc
fig
stimuli
second
turn
upstream
compon
may
lead
chang
found
activ
dcsign
signalosom
bind
increas
expect
littl
chang
occur
exposur
variou
stimuli
mark
contrast
stimuli
result
mark
reduct
pakt
antiapoptot
substanti
increas
proapoptot
studi
latter
detail
found
express
could
reduc
virtual
baselin
level
modc
stimuli
alon
dcsign
blockad
fig
lower
three
panel
observ
indic
ligat
dcsign
either
directli
indirectli
lead
excess
activ
promot
dc
apoptosi
confirm
role
transfect
modc
sirna
treatment
exposur
differ
activ
stimuli
case
silenc
substanti
prevent
excess
dc
apoptosi
respons
activ
factor
fig
therefor
ligat
dcsign
acceler
apoptot
programm
normal
accompani
dc
matur
involv
excess
activ
result
unusu
prematur
cell
death
chronicallyinfect
individu
multipl
subset
dc
peripher
blood
lymphoid
tissu
becom
progress
deplet
diseas
progress
aid
reduct
dc
number
proport
viral
rna
load
unlik
direct
infect
kill
dc
account
substanti
deplet
given
remark
low
frequenc
cell
actual
infect
present
studi
mechan
figur
crosslink
recombin
hiv
serum
sensit
modc
apoptosi
activ
lp
tnfa
dcsign
cell
hiv
blood
presensit
apoptosi
b
modc
treat
ada
presenc
isotyp
control
antidcsign
ab
subsequ
cultur
absenc
presenc
ngml
lp
data
repres
experi
express
mean
sd
b
similar
find
made
treatment
bal
shown
c
modc
treat
antihi
crosslink
recombin
ada
antihi
ab
alon
control
dc
cultur
absenc
activ
presenc
ngml
lp
tnfa
data
repres
mean
sd
experi
modc
treat
normal
ab
serum
sera
viral
rna
copi
n
immunoprecipit
ip
without
prepretreat
plu
antidcsign
mab
subsequ
expos
ngml
lp
may
account
least
part
progress
deplet
convent
dc
subset
seen
chronic
hiv
infect
provid
evid
modc
sensit
crosslink
recombin
fig
sera
fig
undergo
greatli
acceler
apoptosi
respons
ligat
typic
occur
dc
migrat
lymphoid
tissu
extent
dc
apoptosi
proport
concentr
recombin
fig
viral
rna
load
sera
fig
observ
reinforc
find
dcsign
dc
isol
directli
blood
healthi
hiv
individu
could
also
sensit
cell
death
fig
immunoprecipit
sera
substanti
reduc
extent
apoptosi
show
either
virionbound
circul
immunecomplex
form
could
sensit
cell
fig
fraction
hiv
sera
found
kda
virionfre
portion
promot
substanti
level
apoptosi
ligat
wherea
consider
lower
level
induc
kda
virionenrich
portion
fig
sinc
molecular
weight
igg
kda
circul
immunecomplex
would
contain
virionfre
fraction
kda
therefor
immun
complex
primarili
respons
sensit
dc
apoptosi
hiv
serum
test
contain
suffici
quantiti
circul
vivo
sensit
dcsign
dc
apoptosi
howev
remain
studi
smaller
amount
sensit
virionrich
fraction
might
induc
activ
mere
bind
eg
event
viral
entri
evalu
find
directli
isol
dcsign
dc
blood
hiv
individu
found
inde
presensit
apoptosi
ligat
fig
moreov
blood
dc
hiv
individu
modc
sensit
recombin
serum
underw
substanti
apoptosi
exposur
bacteri
lp
proinflammatori
cytokin
tnfa
fig
apart
ligat
amongst
encod
protein
envelop
protein
two
unusu
properti
even
retrovir
envelop
compon
first
loos
attach
virion
rapidli
shed
larg
quantiti
circul
second
liber
bind
activ
high
proport
b
cell
result
massiv
overproduct
antibodi
format
increas
amount
immun
complex
serum
find
reveal
ligat
immunecomplex
dcsign
mannos
ctype
lectin
receptor
mclr
apoptosi
dc
remark
promot
cell
encount
divers
matur
stimuli
otherwis
prerequisit
effect
initi
regul
mani
immun
respons
concentr
free
hiv
serum
studi
mani
group
vari
pm
nm
level
howev
report
determin
free
hiv
serum
employ
antigen
captur
assay
eg
elisa
without
take
account
presenc
ab
serum
could
significantli
mask
detect
free
sometim
complet
abrog
signal
level
free
detect
previou
report
thu
may
repres
antibodybound
demonstr
ab
present
hiv
serum
high
enough
concentr
bind
level
ab
estim
micromolar
rang
therefor
high
affin
bind
nm
ab
virtual
hiv
serum
might
occupi
satur
antibodi
recent
report
estim
level
could
mgml
concentr
form
solubl
cell
virionbound
ad
situat
high
plasma
viremia
concentr
immunecomplex
use
current
studi
therefor
incompat
vivo
scenario
furthermor
interest
note
even
experiment
model
dc
might
differ
reactiv
av
pi
viabil
assay
throughout
entir
studi
around
donor
exagger
pi
stain
promin
av
stain
instanc
fig
vs
like
dc
differ
individu
may
differ
respons
activ
signal
ligat
phenomenon
donortodonor
variat
figur
activ
dc
reduc
express
activ
akt
induct
cell
apoptosi
modc
treat
immunecomplex
ada
expos
tf
mock
tf
lp
tnfa
cellular
protein
modc
recov
cocultur
extract
western
blot
analysi
modc
treat
antihi
ab
use
crosslink
recombin
ada
use
control
control
dc
repres
result
untreat
modc
lane
dc
treat
indic
puls
lane
wherea
repres
result
pretreat
antidcsign
mab
data
repres
experi
b
modc
transfect
sirna
human
control
sirna
scrambl
puls
immunecomplex
subsequ
exposur
tf
lp
tnfa
data
express
mean
sd
experi
recent
report
hiv
bind
modc
induc
impair
product
differenti
respons
ligat
dc
also
report
mous
dc
express
high
could
produc
less
produc
low
dc
deserv
investig
see
express
level
modc
correl
degre
apoptosi
dc
apoptosi
may
also
accompani
product
studi
identifi
membran
receptor
dc
crosslink
hiv
sera
sensit
cell
observ
apoptosi
consider
reduc
pretreat
antagonist
mab
specif
dcsign
combin
chemokin
receptor
fig
fig
contrast
pretreat
dc
crosslink
fc
construct
physiolog
ligand
dcsign
import
stabil
cell
immun
synaps
ineffect
fig
accord
previou
report
bind
site
distinct
solubl
abl
compet
effici
envelop
protein
intact
virus
bind
dcsign
notabl
inhibit
apoptosi
dcsign
blockad
substanti
incomplet
appar
reflect
rel
capac
combin
mab
prevent
bind
dcsign
fig
furthermor
mclr
addit
dcsign
bind
also
involv
dc
apoptosi
pretreat
dc
mannan
led
virtual
complet
diminish
dc
death
contrast
partial
albeit
signific
inhibit
dcsign
blockad
fig
moreov
agre
previou
report
confirm
bind
modc
exclus
carbohydratedepend
bind
capac
deglycosyl
whose
carbohydr
moieti
remov
endoh
treatment
modc
complet
lost
fig
result
total
abrog
apoptosi
fig
f
similar
effect
also
demonstr
use
hiv
serum
fig
also
note
sensit
dc
apoptosi
achiev
crosslink
recombin
presum
immun
complex
hiv
sera
monomer
form
fig
suggest
crosslink
dcsign
requir
sensit
inde
antibodi
crosslink
dcsign
bind
mani
pathogen
shown
initi
divers
intracellular
signal
pathway
dc
lead
differ
cellular
respons
along
thought
block
fc
receptor
fcr
modc
puls
immunecomplex
hiv
serum
order
allow
potent
cluster
dcsign
mclr
inde
result
abund
dc
apoptosi
fig
fig
find
support
involv
dcsign
mclr
sensit
dc
death
anoth
point
support
dcsign
intracellular
signal
apart
sensit
dc
acceler
activationinduc
death
also
induc
phenotyp
chang
dc
typic
matur
fig
role
mclr
dc
phenotyp
matur
also
report
other
therefor
immunecomplex
bind
dcsign
mlcr
may
sensit
dc
prematur
state
may
prerequisit
prompt
dc
vulner
activationinduc
apoptosi
howev
compar
convent
matur
eg
lpstnfa
ligat
phenotyp
matur
appear
ineffici
manifest
less
remark
upregul
downregul
also
less
notic
induc
convent
factor
contrast
mhc
class
ii
upregul
remain
rel
unaffect
fig
ineffici
matur
line
previou
report
bind
mclr
induc
immunosuppress
respons
dc
product
may
subsequ
contribut
weaker
cell
stimul
capac
explor
mechanist
basi
sensit
process
observ
mark
decreas
downstream
antiapoptot
compon
fig
bclxl
fig
turn
upstream
compon
may
account
observ
explain
excess
apoptosi
found
bind
activ
antiapoptot
activ
restrict
caspas
activ
report
other
express
significantli
modul
upon
exposur
matur
stimuli
fig
strikingli
howev
antiapoptot
pakt
markedli
reduc
wherea
proapoptot
substanti
increas
crucial
pretreat
antidcsign
mab
reduc
activ
back
control
level
fig
sirna
silenc
compon
substanti
prevent
dc
apoptosi
fig
henc
bind
dcsign
activ
exposur
differ
matur
stimuli
result
abund
express
may
account
excess
level
apoptosi
whether
directli
due
activ
novel
signal
pathway
ligat
dcsign
anoth
pathway
releas
inhibit
pakt
deserv
attent
furthermor
sinc
nef
suppress
activ
infect
cell
protect
apoptosi
would
interest
determin
whether
infect
dc
protect
similar
manner
uninfect
bystand
cell
kill
base
find
propos
capac
ligat
dcsign
sensit
convent
dc
apoptosi
encount
divers
activ
stimuli
otherwis
induc
cellular
matur
may
account
deplet
dcsign
dc
clearli
demonstr
lymph
node
hiv
patient
spleen
sivinfect
nonhuman
primat
propos
diseas
progress
aid
may
contribut
decreas
capac
mount
effect
immun
respons
also
increas
suscept
multipl
opportunist
infect
fact
type
infect
seen
aid
progress
somewhat
resembl
describ
recent
identifi
dc
defici
syndrom
presenc
lp
result
exampl
mucos
barrier
galt
compromis
concomit
bacteri
infect
also
potenti
hivinduc
immunosuppress
augment
gene
express
least
part
stimul
secret
tnfa
high
level
circul
tnfa
also
detect
hivinfect
individu
factor
could
well
predispos
bystand
dcsign
cell
presensit
serum
exorbit
apoptosi
lymphoid
tissu
blood
broader
context
clear
mani
pathogen
may
also
bind
dcsign
subvert
dc
function
dcsign
ligat
modul
tlrassoci
activ
therefor
deserv
studi
pathogen
also
decreas
surviv
dc
capac
crosslink
dcsign
also
whether
subsequ
modul
tlr
respons
addit
synergist
contribut
defect
pathogenspecif
immun
aid
warrant
investig
narrow
context
also
clear
mani
mechan
contribut
deplet
differ
subset
dc
infect
includ
neg
control
number
plasmacytoid
dc
type
interferon
whether
bind
membran
receptor
dc
sensit
respect
subset
apoptosi
also
need
clarifi
final
acceler
activationinduc
apoptosi
dc
accompani
excess
activ
silenc
prevent
apoptosi
impli
antagonist
therapi
shown
reduc
siv
enceph
macaqu
might
valu
prevent
dc
deplet
diseas
progress
prepar
monocytederiv
dc
treatment
recombin
treatment
monocytederiv
dc
modc
gener
cultur
supplement
autolog
serum
gmcsf
describ
modc
purifi
two
round
immunomagnet
deplet
dynabead
dynal
oslo
norway
use
monoclon
antibodi
mab
bd
pharmingen
san
diego
ca
usa
result
hladr
high
cell
popul
pure
data
shown
recombin
histag
ada
flagtag
bal
prepar
describ
contain
euml
lp
limulu
amebocyt
lysat
lal
assay
modc
cultur
tissu
cultur
plate
corn
life
scienc
corp
usa
h
cultur
medium
describ
nm
recombin
ada
bal
use
crosslink
incub
h
respect
antihi
mous
isotyp
antiflag
mous
isotyp
mab
sigmaaldrich
usa
molar
ratio
vs
antihi
antiflag
mab
result
final
crosslink
nm
therefor
use
immunecomplex
rather
monomer
form
unless
otherwis
state
experi
remov
carbohydr
moieti
enzymat
digest
pretreat
monomer
recombin
endobnglucosaminidas
h
endoh
new
england
biolab
cambridg
mass
usa
incub
recombin
supernat
ku
endohml
hour
describ
extent
deglycosyl
examin
confirm
sdspage
western
blot
analysi
use
polyclon
rabbit
antibodi
fig
crosslink
endohtr
monomer
polyhi
flag
cooh
terminu
antihi
antiflag
ab
form
immunecomplex
dimer
describ
crosslink
endohtr
untreat
examin
western
blot
analysi
nativ
nonreduc
condit
confirm
dimer
addit
antihi
antiflag
ab
fig
bind
endotr
anduntr
dimer
modc
subsequ
compar
flow
cytometri
demonstr
endohtr
lost
bind
modc
fig
block
bind
chemokin
receptor
dc
pretreat
h
mgml
plu
either
clone
mous
mab
clone
mous
bd
pharmingen
san
diego
ca
usa
block
dcsign
dc
similarli
pretreat
antidcsign
mab
clone
mous
r
system
mn
usa
plu
mous
aid
research
refer
reagent
program
nih
combin
mgml
combin
antidcsign
mab
significantli
inhibit
bind
dcsigntransfect
cell
fig
uptak
dcsigntransfect
cell
kind
gift
dr
v
kewalramani
hiv
drug
resist
program
nation
cancer
institut
frederick
nih
md
usa
fig
solubl
polyhistidin
tag
chimer
protein
r
system
abingdon
uk
fig
crosslink
antihi
ab
also
use
pretreat
dc
mgml
h
use
pretreat
receptor
anatagonist
dc
wash
treat
without
recombin
hiv
serum
experi
examin
effect
mannan
compet
bind
also
fcr
block
enhanc
bind
preincub
modc
mannan
mgml
sigma
usa
ml
fcr
block
reagent
miltenyl
biotec
usa
antidcsign
mab
describ
minut
puls
endohtr
untreat
puls
subsequ
day
cocultur
tf
cocultur
activ
cell
autolog
cell
isol
peripher
blood
mononuclear
cell
pbmc
two
round
immunomagnet
deplet
dynabead
dynal
oslo
norway
use
cocktail
mab
hladr
bd
pharmingen
san
diego
ca
usa
result
cell
data
shown
activ
cell
prepar
treat
cell
ngml
pma
mgml
ionomycin
sigma
st
loui
usa
h
express
high
level
fig
left
panel
wherea
express
low
undetect
cell
data
shown
recombin
modc
cocultur
activ
cell
plate
cell
stain
annexin
vfitc
propidium
iodid
bd
pharmingen
san
diego
usa
apoptosi
dc
determin
annexin
vfitc
propidium
iodid
stain
larg
granular
cell
fscssc
plot
use
facscalibur
instrument
becton
dickinson
san
diego
ca
usa
larg
granular
cell
confirm
lack
express
express
high
level
dcsign
fig
block
ligand
activ
cell
treat
mgml
ligand
mab
alexi
lausen
switzerland
h
wash
cocultur
cultur
transfect
lp
tnfa
purifi
modc
treat
crosslink
recombin
h
without
prior
receptor
blockad
cocultur
ligandtransfect
l
tf
cell
kind
gift
dr
yongjun
liu
md
anderson
cancer
center
texa
usa
plate
transfect
express
high
level
similar
activ
cell
fig
right
panel
cocultur
tf
cell
treat
mgml
mitomycin
c
sigma
st
loui
mo
usa
minut
order
prevent
cellular
prolifer
day
cocultur
cell
stain
cychromelabel
antihladr
mab
bd
pharmingen
san
diego
usa
annexin
vfitc
propidium
iodid
essenti
modc
could
harvest
vigor
pipet
resuspens
separ
firmli
adher
tf
cell
recov
cell
express
high
level
hladr
wherea
virtual
cell
remain
well
express
hladr
detach
edta
fig
surviv
determin
annexin
v
andor
propidium
iodid
stain
cell
hladr
gate
popul
trypan
blue
stain
fig
cocultur
mock
transfect
l
cell
use
control
apoptosi
dc
also
examin
cultur
dc
ngml
lp
salmonella
typhosa
sigma
st
loui
usa
tnfa
peprotech
nj
usa
dcsign
cell
isol
individu
describ
briefli
pbmc
collect
buffi
coat
healthi
individu
b
nk
cell
remov
immunomagnet
deplet
dynabead
dynal
oslo
norway
cocktail
mab
bd
pharmingen
san
diego
ca
usa
cell
subsequ
stain
peconjug
bd
pharmingen
ca
usa
plu
fitcconjug
antidcsign
beckman
coulter
ca
usa
mab
subject
posit
sort
use
fac
vantag
bd
bioscienc
ca
usa
yield
dcsign
cell
rang
cell
ie
start
pbmc
popul
cell
cultur
h
presenc
mm
edta
remov
bound
mab
wash
cultur
fresh
medium
addit
h
dcsign
cell
expos
recombin
ada
cocultur
transfect
assess
cell
viabil
dcsign
cell
similarli
isol
pbmc
individu
ethic
review
tabl
yield
rang
cell
start
pbmc
cell
treat
cocultur
tf
cell
expos
ngml
lp
tnfa
prior
analysi
cell
viabil
serum
pbmc
hiv
individu
obtain
blood
collect
genotyp
studi
whole
hiv
serum
provid
aid
research
laboratori
depart
microbiolog
queen
mari
hospit
univers
hong
kong
approv
institut
review
board
use
sera
tabl
centrifug
ultracentrifug
filter
millipor
usa
cutoff
point
kda
fraction
kda
reconstitut
origin
volum
fresh
medium
previous
describ
immunoprecipit
ip
mab
perform
describ
result
reduct
level
fig
indic
kda
fraction
fraction
centrifug
ultracentrifug
filter
cutoff
point
kda
kda
kda
portion
reconstitut
origin
volum
fresh
medium
modc
gener
pbmc
hiv
individu
expos
respect
hiv
serum
fraction
h
room
temperatur
wash
cocultur
tf
autolog
activ
cell
ngml
lp
recoveri
adher
tf
cell
fig
apoptosi
modc
determin
annexin
v
pi
stain
altern
biosafeti
reason
cocultur
activ
cell
apoptosi
determin
termin
deoxynucleotidyl
transferas
tdt
dutp
nick
end
label
tunel
assay
use
insitu
cell
death
detect
kit
roch
diagnost
inc
accord
manufactur
instruct
recov
modc
fix
permeabil
subject
tunel
reaction
mix
incub
h
follow
cytometr
analysi
purifi
modc
puls
without
whole
sera
recombin
ada
h
wash
respect
cocultur
tf
cell
lp
tnfa
describ
modc
could
separ
tf
recov
pipet
resuspens
cocultur
well
preliminari
experi
recov
cell
confirm
express
high
mhc
class
ii
hladr
tf
could
subsequ
detach
treatment
mm
edta
min
express
littl
mhc
class
ii
fig
recov
modc
wash
icecold
pb
lyse
buffer
contain
proteinas
inhibitor
cocktail
sigma
st
loui
usa
mg
total
cell
lysat
protein
aliquot
load
onto
polyacrylamid
gel
subject
sdspage
analysi
gel
blot
onto
immobilon
p
membran
millipor
bedford
mass
usa
block
trisbuff
salin
tb
contain
tween
tbst
milk
probe
primari
mab
human
bclxl
zyme
laboratori
inc
ca
usa
dilut
phosphoakt
phosphocraf
rabbit
polyclon
antibodi
cell
signal
usa
bactin
santa
cruz
ca
usa
overnight
membran
wash
incub
horseradish
peroxidaseconjug
secondari
antibodi
santa
cruz
ca
usa
h
room
temperatur
wash
membran
develop
ecl
enhanc
chemiluminesc
western
blot
kit
expos
hyperfilm
amersham
pharmacia
biotech
inc
piscataway
nj
usa
room
temperatur
rabbit
polyclon
ab
confirm
detect
express
cell
transfect
human
fig
transfect
modc
sirna
human
control
sirna
mm
santa
cruz
usa
perform
describ
oligofectamin
follow
protocol
accord
manufactur
instruct
invitrogen
carlsbad
ca
usa
day
modc
transfect
day
puls
immunecomplex
data
present
mean
standard
deviat
analyz
anova
use
spss
softwar
modc
puls
crosslink
immunecomplex
cocultur
autolog
activ
cell
day
analyz
viabil
av
pi
stain
result
show
percentag
av
pi
cell
right
lower
quadrant
increas
decreas
wherea
av
pi
cell
right
upper
quadrant
increas
increas
total
av
cell
includ
avpi
cell
nevertheless
remain
rel
consist
vs
find
line
result
fig
text
indic
incub
time
increas
cell
earli
apoptot
phase
would
becom
late
apoptot
avpi
cell
result
repres
experi
tif
figur
endoh
treatment
recombin
abolish
bind
modc
recombin
ada
supernat
treat
overnight
ku
endohml
describ
hong
pwp
et
al
j
virol
treat
untreat
ada
supernat
subject
western
blot
assay
polyclon
rabbit
ab
sino
biolog
inc
untreat
mw
kda
wherea
endohtr
one
mw
kda
b
endohuntr
recombin
ada
crosslink
antihi
antiflag
ab
describ
materi
method
subsequ
subject
nativ
nonreduc
western
blot
analysi
describ
hong
treat
without
control
antidcsign
mab
clone
individu
combin
mgml
h
wash
cell
incub
h
mgml
recombin
ada
crosslink
fitcconjug
antihi
mab
recombin
iiib
mn
crosslink
mab
nih
aid
research
refer
reagent
program
indic
wash
analys
flow
cytometri
shade
area
bind
recombin
solid
line
bind
pretreat
antidcsign
mab
dash
line
bind
mock
transfect
note
effect
inhibit
though
still
incomplet
bind
seen
combin
antidcsign
mab
effect
test
individu
data
repres
experi
b
dcsigntransfect
tf
mocktransfect
cell
incub
ng
nih
aid
research
refer
reagent
program
total
volum
ml
hour
allow
cellular
adsorpt
viru
viral
replic
cell
pretreat
without
combin
antidcsign
mab
clone
plu
room
temperatur
minut
prior
exposur
viru
supernat
subsequ
cultur
cell
wash
extens
remov
unbound
viru
lyse
triton
lysat
subject
analysi
use
elisa
kit
coulter
fl
usa
crosslink
ada
respect
crosslink
antihi
antiflag
mab
panel
e
f
respect
cocultur
transfect
day
antibodi
use
nm
nm
flow
cytometr
analysi
confirm
littl
apoptosi
mabtreat
modc
panel
ad
compar
panel
e
f
data
repres
experi
experi
treatment
combin
three
mab
induc
tfmediat
dc
apoptosi
either
data
shown
tif
figur
modc
treat
hiv
sera
identifi
distinctli
smallers
popul
compar
control
modc
modc
treat
normal
ab
serum
control
dc
serum
hiv
serumdc
viral
load
tabl
endoh
ml
ml
proteas
inhibitor
complet
ultra
tablet
edtafre
roch
order
protect
integr
endoh
addit
serum
mix
ml
hiv
serum
viral
titer
tabl
minut
ultracentrifug
obtain
kda
fraction
describ
materi
method
dc
puls
endohtr
untreat
hiv
serum
kda
fraction
pretreat
without
mannan
fcr
block
reagent
describ
fig
text
antidcsign
mab
subsequ
cocultur
tf
day
dc
detach
recov
underw
avpi
stain
dc
puls
normal
ab
serum
use
control
result
reveal
dc
puls
endohtr
hiv
serum
signific
reduct
apoptosi
control
level
compar
cell
puls
endohuntr
hiv
serum
furthermor
consist
use
recombin
fcr
block
induc
excess
apoptosi
control
dc
puls
normal
ab
serum
fcr
blockad
dc
prior
puls
hiv
serum
increas
extent
apoptosi
comparison
fcr
blockad
addit
compar
dcsign
blockad
partial
prevent
dc
death
compar
dc
without
dcsign
blockad
pretreat
dc
mannan
reduc
dc
apoptot
compar
dcsign
blockad
repres
independ
experi
shown
total
av
cell
condit
express
mean
sd
b
tif
figur
freshlyisol
dcsign
cell
blood
express
dcsign
cell
gate
left
panel
isol
subset
pbmc
describ
materi
method
cell
incub
fitcconjug
mab
bd
pharmingen
ca
usa
analyz
flow
cytometri
middl
right
panel
line
previou
report
figur
crosslink
modul
express
surfac
molecul
typic
associ
dc
matur
dcsigndepend
manner
ineffici
compar
matur
convent
factor
modc
cultur
h
presenc
mgml
monomer
ada
left
column
antihi
crosslink
ada
mgml
middl
column
antihi
crosslink
ada
dcsign
blockad
mgml
antidcsign
mab
clone
right
column
result
indic
immunecomplex
inde
could
induc
phenotyp
matur
modc
manifest
clear
upregul
downregul
modul
could
part
prevent
pretreat
antidcsign
mab
right
column
chang
hladr
express
remark
other
data
repres
experi
b
modc
treat
dimer
crosslink
mgml
convent
dc
matur
factor
similarli
describ
et
al
plo
pathogen
ie
exposur
mixtur
ng
ml
lp
ngml
tnfa
ngml
simultan
cocultur
describ
materi
method
h
dc
treatment
use
control
control
dc
treatment
dc
subject
flow
cytometr
analysi
surfac
express
costimulatori
matur
marker
compar
convent
matur
induc
ineffici
modul
modc
upregul
well
downregul
contrast
upregul
mhc
class
ii
appear
less
affect
data
repres
independ
experi
tif
figur
express
antiapoptot
bclxl
reduc
cocultur
modc
transfect
rabbit
polyclon
ab
detect
express
cell
modc
treat
crosslink
ada
antihi
mab
control
dc
follow
cocultur
tf
dc
harvest
lyse
cellular
protein
subject
western
blot
indic
protein
data
repres
experi
b
modc
treat
serum
rna
copi
without
pretreat
antidcsign
mab
describ
materi
method
prior
cocultur
transfect
describ
panel
cellular
protein
extract
subject
western
blot
indic
protein
hour
cell
lyse
subject
western
blot
assay
rabbit
polyclon
ab
antibodi
cell
signal
usa
result
confirm
express
molecular
weight
kda
serv
posit
control
express
fig
data
repres
independ
experi
tif
tabl
viral
rna
copi
number
sera
infect
individu
use
studi
patient
viral
rna
copi
number
retriev
archiv
inform
follow
individu
pool
patient
sampl
use
obtain
data
shown
respect
figur
figur
